- Home
- SAVE vs OBIO Comparison
SAVE vs OBIO Comparison
Compare SAVE & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVE
- OBIO
- Stock Information
- Founded
- SAVE 1964
- OBIO 2017
- Country
- SAVE United States
- OBIO United States
- Employees
- SAVE N/A
- OBIO N/A
- Industry
- SAVE Air Freight/Delivery Services
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- SAVE Consumer Discretionary
- OBIO Health Care
- Exchange
- SAVE Nasdaq
- OBIO Nasdaq
- Market Cap
- SAVE 203.7M
- OBIO 200.1M
- IPO Year
- SAVE 2011
- OBIO N/A
- Fundamental
- Price
- SAVE $1.08
- OBIO $5.84
- Analyst Decision
- SAVE Sell
- OBIO Strong Buy
- Analyst Count
- SAVE 9
- OBIO 4
- Target Price
- SAVE $2.00
- OBIO $15.75
- AVG Volume (30 Days)
- SAVE 26.9M
- OBIO 57.1K
- Earning Date
- SAVE 11-26-2024
- OBIO 11-12-2024
- Dividend Yield
- SAVE 111.11%
- OBIO N/A
- EPS Growth
- SAVE N/A
- OBIO N/A
- EPS
- SAVE N/A
- OBIO N/A
- Revenue
- SAVE $5,126,729,000.00
- OBIO $2,647,000.00
- Revenue This Year
- SAVE N/A
- OBIO $7.68
- Revenue Next Year
- SAVE N/A
- OBIO $110.40
- P/E Ratio
- SAVE N/A
- OBIO N/A
- Revenue Growth
- SAVE N/A
- OBIO N/A
- 52 Week Low
- SAVE $1.03
- OBIO $4.22
- 52 Week High
- SAVE $17.02
- OBIO $11.69
- Technical
- Relative Strength Index (RSI)
- SAVE 34.79
- OBIO 51.19
- Support Level
- SAVE $1.13
- OBIO $5.56
- Resistance Level
- SAVE $3.64
- OBIO $6.50
- Average True Range (ATR)
- SAVE 0.28
- OBIO 0.53
- MACD
- SAVE -0.17
- OBIO 0.00
- Stochastic Oscillator
- SAVE 1.82
- OBIO 56.58
About SAVE Spirit Airlines Inc.
Spirit Airlines Inc serves the United States, Latin America, and Caribbean as an airline operator. It primarily offers customers unbundled base fares to strip out any unneeded travel amenities. If needed, a customer can elect for additional options at an extra charge. Flight crews are entirely interchangeable across all aircraft, and maintenance and other support services are simplified due to not having an overly complex fleet. The company has one operating segment, air transportation, owing to its system wide route structure. It may decide to expand its network if a market is underserved or overpriced. The majority of revenue is derived from the United States.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.